DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q4 2023

SEC EDGAR SourceSEC Filings

Top Holdings379 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3.6M$371.6M4.5%$62.43+62.06%
20 qtrssince 2019-Q1
Increased
66

XENON PHARMACEUTICALS INC

4.3M$200.1M2.4%$26.71+72.45%
16 qtrssince 2020-Q1
Decreased
0

CRINETICS PHARMACEUTICALS IN

5M$179.3M2.2%$20.83+70.80%
15 qtrssince 2020-Q2
Decreased
0

CAMTEK LTD

2M$142.2M1.7%$63.43+7.62%
2 qtrssince 2023-Q3
Increased
65

CAMECO CORP

3.2M$137.6M1.7%$26.51+61.92%
10 qtrssince 2021-Q3
Decreased
0
446,128$126.8M1.5%
5 qtrssince 2022-Q4
Decreased
0
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

5.2M$123.4M1.5%$16.02+46.38%
20 qtrssince 2019-Q1
Decreased
0
GPCRGPCR
ADR

STRUCTURE THERAPEUTICS INC

2.6M$105.9M1.3%$38.65+5.47%
4 qtrssince 2023-Q1
Increased
51

VAXCYTE INC

1.7M$105.2M1.3%$44.67+40.58%
8 qtrssince 2022-Q1
Increased
58

FTAI AVIATION LTD

2.1M$99.7M1.2%$27.55+63.57%
4 qtrssince 2023-Q1
Increased
49

BELLRING BRANDS INC

1.8M$99.4M1.2%$34.14+62.37%
5 qtrssince 2022-Q4
Increased
52

AXON ENTERPRISE INC

343,377$88.7M1.1%$164.66+56.89%
17 qtrssince 2019-Q4
Increased
52

SAIA INC

201,446$88.3M1.1%$263.70+66.18%
5 qtrssince 2022-Q4
Increased
54

ONTO INNOVATION INC

569,911$87.1M1.0%$136.01+12.42%
2 qtrssince 2023-Q3
Increased
65

TransMedics Group, Inc.

1.1M$86.1M1.0%$44.82+76.12%
7 qtrssince 2022-Q2
Increased
51

MONDAY COM LTD

431,722$81.1M1.0%$150.37+24.90%
4 qtrssince 2023-Q1
Decreased
0
EPIEPI
ETF

WISDOMTREE TR

1.9M$79M1.0%$27.12+50.77%
19 qtrssince 2019-Q2
Unchanged
0
FMXFMX
Unit

FOMENTO ECONOMICO MEXICANO SAB /1 ADR REPRS 10 UT CONS 10 SERB &20 SER D-B SHS &20 SER D-L/

595,481$77.6M0.9%$100.97+16.22%
3 qtrssince 2023-Q2
Increased
48

e.l.f. Beauty, Inc.

535,603$77.3M0.9%$34.39+319.77%
8 qtrssince 2022-Q1
Decreased
0
CYBRCYBRDelisted

CYBERARK SOFTWARE LTD

334,942$73.4M0.9%$170.97+28.12%
9 qtrssince 2021-Q4
Increased
51
$8.3B
AUM
379
Positions
Q4 2023
Filing
Rating · 2.0
Quarterly Portfolio Change
+7%Q3'22$6.6B+2%Q4'22$6.7B+6%Q1'23$7.1B+11%Q2'23$7.9B-3%Q3'23$7.7B+8%Q4'23$8.3B
Activity profile
$ moved · Q4'23
New21%Increased32%Decreased24%Exited22%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.5 years
<1Q9%1-4Q20%1-2Y13%2Y+58%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $8.3B across 379 positions as of Q4 2023. Top holdings: TSM (4.5%), XENE (2.4%), CRNX (2.2%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q4 2023 Summary

Active quarter - 94 new positions, 106 exits, 117 increased. Top move: TSM (INCREASED, conviction 66). Portfolio: $8.3B across 379 positions.

Top holdings by portfolio weight

Total AUM$8B
TSM4.48%
XENE2.41%
CRNX2.16%
CAMT1.71%
CCJ1.66%
MS51.53%
IBN1.49%
GPCR1.28%
PCVX1.27%
FTAI1.20%
Other1.20%

Portfolio allocation by GICS sector

Sectors11
Technology21.14%
Industrials20.69%
Healthcare18.61%
Consumer Cyclical8.59%
Financial Services8.16%
Unknown7.23%
Consumer Defensive5.89%
Energy4.84%
Basic Materials2.86%
Communication Services1.75%
Other0.24%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Technology, Industrials, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used